A Real-World Study of β-Thalassemia Major Treatment With Luspatercept in Taiwan

NCT06596642 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

β-Thalassemia Major

Interventions

DRUG: Luspatercept

Sponsor

Bristol-Myers Squibb